BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 20429850)

  • 1. Targeting lymphocyte co-stimulation: from bench to bedside.
    Felix NJ; Suri A; Salter-Cid L; Nadler SG; Gujrathi S; Corbo M; Aranda R
    Autoimmunity; 2010 Nov; 43(7):514-25. PubMed ID: 20429850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction.
    Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M
    Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells.
    Park W; Weyand CM; Schmidt D; Goronzy JJ
    Eur J Immunol; 1997 May; 27(5):1082-90. PubMed ID: 9174596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.
    Harding FA; McArthur JG; Gross JA; Raulet DH; Allison JP
    Nature; 1992 Apr; 356(6370):607-9. PubMed ID: 1313950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lymphocyte coreceptors].
    Olive D
    Med Sci (Paris); 2006 Dec; 22(12):1069-74. PubMed ID: 17156728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements for stimulation or anergy induction in alloreactive human T cell clones.
    Pawelec G; Kalbacher H; Pohla H; Boshell M; Max H; Friccius H; Adibzadeh M; Hambrecht A; Sansom D
    Cell Immunol; 1994 Oct; 158(1):241-52. PubMed ID: 7522128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40/CD40L interaction is essential for the induction of EAE in the absence of CD28-mediated co-stimulation.
    Girvin AM; Dal Canto MC; Miller SD
    J Autoimmun; 2002 Mar; 18(2):83-94. PubMed ID: 11908941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
    Peggs KS; Quezada SA; Allison JP
    Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
    Allen SD; Rawale SV; Whitacre CC; Kaumaya PT
    J Pept Res; 2005 Jun; 65(6):591-604. PubMed ID: 15885118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of tolerance induction: blockade of co-stimulation.
    Sebille F; Vanhove B; Soulillou JP
    Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):649-57. PubMed ID: 11375068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional roles for T cell CD40 in infection and autoimmune disease: the role of CD40 in lymphocyte homeostasis.
    Munroe ME
    Semin Immunol; 2009 Oct; 21(5):283-8. PubMed ID: 19539498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ICOS is critical for CD40-mediated antibody class switching.
    McAdam AJ; Greenwald RJ; Levin MA; Chernova T; Malenkovich N; Ling V; Freeman GJ; Sharpe AH
    Nature; 2001 Jan; 409(6816):102-5. PubMed ID: 11343122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive and autoimmune effects of thimerosal in mice.
    Havarinasab S; Häggqvist B; Björn E; Pollard KM; Hultman P
    Toxicol Appl Pharmacol; 2005 Apr; 204(2):109-21. PubMed ID: 15808517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting costimulatory pathways for tumor immunotherapy.
    Ward RC; Kaufman HL
    Int Rev Immunol; 2007; 26(3-4):161-96. PubMed ID: 17558743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICAM-1 co-stimulates target cells to facilitate antigen presentation.
    Lebedeva T; Dustin ML; Sykulev Y
    Curr Opin Immunol; 2005 Jun; 17(3):251-8. PubMed ID: 15886114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of costimulatory molecules in autoimmunity.
    Kobata T; Azuma M; Yagita H; Okumura K
    Rev Immunogenet; 2000; 2(1):74-80. PubMed ID: 11324695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
    Gao W; Demirci G; Strom TB; Li XC
    Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives.
    Nakken B; Munthe LA; Konttinen YT; Sandberg AK; Szekanecz Z; Alex P; Szodoray P
    Autoimmun Rev; 2011 Nov; 11(1):28-34. PubMed ID: 21777703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation.
    Saverino D; Brizzolara R; Simone R; Chiappori A; Milintenda-Floriani F; Pesce G; Bagnasco M
    Clin Immunol; 2007 May; 123(2):190-8. PubMed ID: 17321799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28 and T cell co-stimulation.
    Holdorf AD; Kanagawa O; Shaw AS
    Rev Immunogenet; 2000; 2(2):175-84. PubMed ID: 11258416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.